Market Research Logo

Corneal Implants Market Size By Tissue Type (Human Donor, Artificial Cornea), By Transplant Type (Anterior Lamellar Keratoplasty, Endothelial Lamellar Keratoplasty, Penetrating Keratoplasty), By Condition (Fungal Keratitis, Fuchs Dystrophy, Keratoconus),

Corneal Implants Market will exceed USD 500 million by 2025; as per a new research report.

Increasing demand for minimally invasive eye surgical procedures globally has positively influenced corneal implants industry growth during forecast years. Conventional treatment options for corneal diseases have proven to be risky due to complexity involved. To cater to this problem, researchers have developed innovative techniques that involves placing of donor tissue from second layer of cornea. Newly introduced techniques of corneal implants strengthened and flattened the cornea thereby, improving eye sight of the patients suffering from keratoconus. As recently manufactured artificial corneal implants are utilized in these minimally invasive procedures, the corneal implants industry will offer numerous growth opportunities.

Growing elderly population base in developed economies is one of the major factors driving industry growth as majority of them suffer from eye disorders. According to National Eye Institute, around 2.1 million elderly Americans have age-related macular degeneration. In countries such as the U.S. and Germany, geriatric population suffering from diabetes has high prevalence of diabetic retinopathy. This scenario proves beneficial for corneal implants market growth as it substantially augments demand of corneal implants. However, shortage of human donor material will affect the industry growth to some extent in coming years.

Artificial corneal implants segment witnessed around 10% CAGR throughout the analysis period. Recently developed artificial corneal implants are considered as a substitute for patients that cannot tolerate human donor cornea. According to Cornea Research Foundation of America, around 10 million people suffer from corneal blindness globally out of which only 100,000 corneal implant procedures get access to human donor tissue. Thus, crisis of human donor tissue has boosted the demand for artificial corneal implants, thereby escalating the segment growth.

Penetrating keratoplasty segment accounted for 47% in 2018. Demand for penetrating keratoplasty is projected to grow gradually in the near future. This procedure is completed in one or two hours and performed on outpatient basis. Thus, patients are able to resume to daily activities in few hours. As recovery time is less its demand is expected to grow over forecast period. Also, plastic shield utilized in these procedures protects eye and enhances healing process that further propels its demand.

Keratoconus segment is projected to have more than 6% growth during analysis timeframe. This condition is predicted to damage cornea and affect vision. Mostly, the patients suffering from keratoconus disease experience distortion of vision causing obstruction in performing daily tasks. This raises the demand for corneal transplant procedures thereby, positively impacting the segmental growth in forthcoming years.

Eye clinics segment was valued over USD 49 million in 2018 and is projected to have significant growth throughout the analysis timeframe. Eye clinics have expertise that help in diagnosing the eye disease. However, some of these clinics are not self-sufficient to perform surgeries and non-invasive transplant procedures due to budget constraints. Physicians and eye specialists working at eye clinics refer patients to hospitals that are well-equipped and perform surgical procedures.

North America corneal implants market held over 60% revenue share in 2018. Considerable regional market share can be attributed to the huge geriatric population suffering from eye diseases and requiring corneal transplant treatment. Favorable demographic trends coupled with supportive regulatory scenario for corneal implants should elevate regional market growth. Also, people suffering from keratoconus and Fuchs' Dystrophy have immense preference for minimally invasive corneal transplant procedures that proves beneficial for the regional market growth.

Asia-Pacific corneal implants market is expected to grow at 8% during analysis timeframe. Countries such as China, Japan and India have high prevalence of eye diseases as majority of the population suffers from diabetes that affects the vision. Moreover, people in these countries are becoming aware regarding availability of superior quality artificial corneal transplants that should trigger the regional market growth in coming years.

Prominent market players operating in the corneal implants market include Alabama Eye Bank, Alcon, Florida Lions Eye Bank, Presbia, San Diego Eye Bank, CorNeat Vision, Aurolab, DIPOTEX, AJL Ophthalmic SA (Intacs), KeraMed and Massachusetts Eye and Ear. Due to intense competition, these industry players implement inorganic growth strategies such as acquisitions and mergers that helps them in gaining substantial market share. For instance, in March 2019, Alcon Inc., acquired PowerVision, Inc., a U.S. based medical device company involved in development of fluid-based intraocular lens implants. This strategy aims to develop innovative and accommodating lens for cataract patients across the world.


Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Corneal implants industry 360 degree synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Tissue type trends
2.1.3. Transplant type trends
2.1.4. Condition trends
2.1.5. End-use trends
2.1.6. Regional trends
Chapter 3. Corneal Implants Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 - 2025
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing incidence of eye diseases worldwide
3.3.1.2. Rising elderly population in developed economies
3.3.1.3. Growing demand for minimally invasive surgical procedure across the globe
3.3.2. Industry pitfalls and challenges
3.3.2.1. Risks associated with corneal implants
3.3.2.2. Shortage of donor material worldwide
3.4. Growth potential analysis
3.4.1. By tissue type
3.4.2. By transplant type
3.4.3. By condition
3.4.4. By end-use
3.5. Technology landscape
3.6. Porter's analysis
3.7. Competitive landscape, 2017
3.7.1. Strategy dashboard
3.8. PESTEL analysis
Chapter 4. Corneal Implants Market, By Tissue Type
4.1. Key segment trends
4.2. Human donor
4.2.1. Market size, by region, 2014 - 2025 (USD Million)
4.3. Artificial cornea
4.3.1. Market size, by region, 2014-2025 (USD Million)
Chapter 5. Corneal Implants Market, By Transplant Type
5.1. Key segment trends
5.2. Anterior lamellar keratoplasty (ALK)
5.2.1. Market size, by region, 2014-2025 (USD Million)
5.3. Endothelial lamellar keratoplasty (ELK)
5.3.1. Market size, by region, 2014-2025 (USD Million)
5.4. Penetrating keratoplasty (PK)
5.4.1. Market size, by region, 2014-2025 (USD Million)
5.5. Others
5.5.1. Market size, by region, 2014-2025 (USD Million)
Chapter 6. Corneal Implants Market, By Condition
6.1. Key segment trends
6.2. Fungal keratitis
6.2.1. Market size, by region, 2014-2025 (USD Million)
6.3. Fuchs' dystrophy
6.3.1. Market size, by region, 2014-2025 (USD Million)
6.4. Keratoconus
6.4.1. Market size, by region, 2014-2025 (USD Million)
6.5. Others
6.5.1. Market size, by region, 2014-2025 (USD Million)
Chapter 7. Corneal Implants Market, By End-use
7.1. Key segment trends
7.2. Hospitals
7.2.1. Market size, by region, 2014-2025 (USD Million)
7.3. Eye clinics
7.3.1. Market size, by region, 2014-2025 (USD Million)
7.4. Ambulatory surgical centers (ASCs)
7.4.1. Market size, by region, 2014-2025 (USD Million)
Chapter 8. Corneal Implants Market, By Region
8.1. Key regional trends
8.2. North America
8.2.1. Market size, by country, 2014-2025 (USD Million)
8.2.2. Market size, by tissue type, 2014-2025 (USD Million)
8.2.3. Market size, by transplant type, 2014-2025 (USD Million)
8.2.4. Market size, by condition, 2014-2025 (USD Million)
8.2.5. Market size, by end-use, 2014-2025 (USD Million)
8.2.6. U.S.
8.2.6.1. Market size, by tissue type, 2014-2025 (USD Million)
8.2.6.2. Market size, by transplant type, 2014-2025 (USD Million)
8.2.6.3. Market size, by condition, 2014-2025 (USD Million)
8.2.6.4. Market size, by end-use, 2014-2025 (USD Million)
8.2.7. Canada
8.2.7.1. Market size, by tissue type, 2014-2025 (USD Million)
8.2.7.2. Market size, by transplant type, 2014-2025 (USD Million)
8.2.7.3. Market size, by condition, 2014-2025 (USD Million)
8.2.7.4. Market size, by end-use, 2014-2025 (USD Million)
8.3. Europe
8.3.1. Market size, by country, 2014-2025 (USD Million)
8.3.2. Market size, by tissue type, 2014-2025 (USD Million)
8.3.3. Market size, by transplant type, 2014-2025 (USD Million)
8.3.4. Market size, by condition, 2014-2025 (USD Million)
8.3.5. Market size, by end-use, 2014-2025 (USD Million)
8.3.6. Germany
8.3.6.1. Market size, by tissue type, 2014-2025 (USD Million)
8.3.6.2. Market size, by transplant type, 2014-2025 (USD Million)
8.3.6.3. Market size, by condition, 2014-2025 (USD Million)
8.3.6.4. Market size, by end-use, 2014-2025 (USD Million)
8.3.7. UK
8.3.7.1. Market size, by tissue type, 2014-2025 (USD Million)
8.3.7.2. Market size, by transplant type, 2014-2025 (USD Million)
8.3.7.3. Market size, by condition, 2014-2025 (USD Million)
8.3.7.4. Market size, by end-use, 2014-2025 (USD Million)
8.3.8. France
8.3.8.1. Market size, by tissue type, 2014-2025 (USD Million)
8.3.8.2. Market size, by transplant type, 2014-2025 (USD Million)
8.3.8.3. Market size, by condition, 2014-2025 (USD Million)
8.3.8.4. Market size, by end-use, 2014-2025 (USD Million)
8.3.9. Italy
8.3.9.1. Market size, by tissue type, 2014-2025 (USD Million)
8.3.9.2. Market size, by transplant type, 2014-2025 (USD Million)
8.3.9.3. Market size, by condition, 2014-2025 (USD Million)
8.3.9.4. Market size, by end-use, 2014-2025 (USD Million)
8.3.10. Spain
8.3.10.1. Market size, by tissue type, 2014-2025 (USD Million)
8.3.10.2. Market size, by transplant type, 2014-2025 (USD Million)
8.3.10.3. Market size, by condition, 2014-2025 (USD Million)
8.3.10.4. Market size, by end-use, 2014-2025 (USD Million)
8.4. Asia Pacific
8.4.1. Market size, by country, 2014-2025 (USD Million)
8.4.2. Market size, by tissue type, 2014-2025 (USD Million)
8.4.3. Market size, by transplant type, 2014-2025 (USD Million)
8.4.4. Market size, by condition, 2014-2025 (USD Million)
8.4.5. Market size, by end-use, 2014-2025 (USD Million)
8.4.6. China
8.4.6.1. Market size, by tissue type, 2014-2025 (USD Million)
8.4.6.2. Market size, by transplant type, 2014-2025 (USD Million)
8.4.6.3. Market size, by condition, 2014-2025 (USD Million)
8.4.6.4. Market size, by end-use, 2014-2025 (USD Million)
8.4.7. India
8.4.7.1. Market size, by tissue type, 2014-2025 (USD Million)
8.4.7.2. Market size, by transplant type, 2014-2025 (USD Million)
8.4.7.3. Market size, by condition, 2014-2025 (USD Million)
8.4.7.4. Market size, by end-use, 2014-2025 (USD Million)
8.4.8. Japan
8.4.8.1. Market size, by tissue type, 2014-2025 (USD Million)
8.4.8.2. Market size, by transplant type, 2014-2025 (USD Million)
8.4.8.3. Market size, by condition, 2014-2025 (USD Million)
8.4.8.4. Market size, by end-use, 2014-2025 (USD Million)
8.4.9. Australia
8.4.9.1. Market size, by tissue type, 2014-2025 (USD Million)
8.4.9.2. Market size, by transplant type, 2014-2025 (USD Million)
8.4.9.3. Market size, by condition, 2014-2025 (USD Million)
8.4.9.4. Market size, by end-use, 2014-2025 (USD Million)
8.4.10. South Korea
8.4.10.1. Market size, by tissue type, 2014-2025 (USD Million)
8.4.10.2. Market size, by transplant type, 2014-2025 (USD Million)
8.4.10.3. Market size, by condition, 2014-2025 (USD Million)
8.4.10.4. Market size, by end-use, 2014-2025 (USD Million)
8.5. Latin America
8.5.1. Market size, by country, 2014-2025 (USD Million)
8.5.2. Market size, by tissue type, 2014-2025 (USD Million)
8.5.3. Market size, by transplant type, 2014-2025 (USD Million)
8.5.4. Market size, by condition, 2014-2025 (USD Million)
8.5.5. Market size, by end-use, 2014-2025 (USD Million)
8.5.6. Brazil
8.5.6.1. Market size, by tissue type, 2014-2025 (USD Million)
8.5.6.2. Market size, by transplant type, 2014-2025 (USD Million)
8.5.6.3. Market size, by condition, 2014-2025 (USD Million)
8.5.6.4. Market size, by end-use, 2014-2025 (USD Million)
8.5.7. Mexico
8.5.7.1. Market size, by tissue type, 2014-2025 (USD Million)
8.5.7.2. Market size, by transplant type, 2014-2025 (USD Million)
8.5.7.3. Market size, by condition, 2014-2025 (USD Million)
8.5.7.4. Market size, by end-use, 2014-2025 (USD Million)
8.5.8. Argentina
8.5.8.1. Market size, by tissue type, 2014-2025 (USD Million)
8.5.8.2. Market size, by transplant type, 2014-2025 (USD Million)
8.5.8.3. Market size, by condition, 2014-2025 (USD Million)
8.5.8.4. Market size, by end-use, 2014-2025 (USD Million)
8.6. Middle East and Africa
8.6.1. Market size, by country, 2014-2025 (USD Million)
8.6.2. Market size, by tissue type, 2014-2025 (USD Million)
8.6.3. Market size, by transplant type, 2014-2025 (USD Million)
8.6.4. Market size, by condition, 2014-2025 (USD Million)
8.6.5. Market size, by end-use, 2014-2025 (USD Million)
8.6.6. South Africa
8.6.6.1. Market size, by tissue type, 2014-2025 (USD Million)
8.6.6.2. Market size, by transplant type, 2014-2025 (USD Million)
8.6.6.3. Market size, by condition, 2014-2025 (USD Million)
8.6.6.4. Market size, by end-use, 2014-2025 (USD Million)
8.6.7. Saudi Arabia
8.6.7.1. Market size, by tissue type, 2014-2025 (USD Million)
8.6.7.2. Market size, by transplant type, 2014-2025 (USD Million)
8.6.7.3. Market size, by condition, 2014-2025 (USD Million)
8.6.7.4. Market size, by end-use, 2014-2025 (USD Million)
8.6.8. UAE
8.6.8.1. Market size, by tissue type, 2014-2025 (USD Million)
8.6.8.2. Market size, by transplant type, 2014-2025 (USD Million)
8.6.8.3. Market size, by condition, 2014-2025 (USD Million)
8.6.8.4. Market size, by end-use, 2014-2025 (USD Million)
Chapter 9. Company Profiles
9.1. Alabama Eye Bank Inc
9.1.1. Business overview
9.1.2. Financial data
9.1.3. Product landscape
9.1.4. Strategic outlook
9.1.5. SWOT analysis
9.2. Alcon Inc.
9.2.1. Business overview
9.2.2. Financial data
9.2.3. Product landscape
9.2.4. Strategic outlook
9.2.5. SWOT analysis
9.3. Florida Lions Eye Bank
9.3.1. Business overview
9.3.2. Financial data
9.3.3. Service landscape
9.3.4. Strategic outlook
9.3.5. SWOT analysis
9.4. Presbia PLC
9.4.1. Business overview
9.4.2. Financial data
9.4.3. Product landscape
9.4.4. Strategic outlook
9.4.5. SWOT analysis
9.5. San Diego Eye Bank
9.5.1. Business overview
9.5.2. Financial data
9.5.3. Service landscape
9.5.4. Strategic outlook
9.5.5. SWOT analysis
9.6. CorNeat Vision Ltd.
9.6.1. Business overview
9.6.2. Financial data
9.6.3. Product landscape
9.6.4. Strategic outlook
9.6.5. SWOT analysis
9.7. Aurolab
9.7.1. Business overview
9.7.2. Financial data
9.7.3. Product landscape
9.7.4. Strategic outlook
9.7.5. SWOT analysis
9.8. DIPOTEX
9.8.1. Business overview
9.8.2. Financial data
9.8.3. Product landscape
9.8.4. Strategic outlook
9.8.5. SWOT analysis
9.9. AJL Ophthalmic SA (Intacs)
9.9.1. Business overview
9.9.2. Financial data
9.9.3. Product landscape
9.9.4. Strategic outlook
9.9.5. SWOT analysis
9.10. KeraMed, Inc.
9.10.1. Business overview
9.10.2. Financial data
9.10.3. Product landscape
9.10.4. Strategic outlook
9.10.5. SWOT analysis
9.11. Massachusetts Eye and Ear
9.11.1. Business overview
9.11.2. Financial data
9.11.3. Product landscape
9.11.4. Strategic outlook
9.11.5. SWOT analysis
Data Tables
TABLE 1 Corneal implants industry 36 degree synopsis, 2014 - 2025
TABLE 2 Corneal implants market, 2014 - 2025 (USD Million)
TABLE 3 Corneal implants market, by tissue type, 2014 - 2025 (USD Million)
TABLE 4 Corneal implants, by transplant type, 2014 - 2025 (USD Million)
TABLE 5 Corneal implants, by condition, 2014 - 2025 (USD Million)
TABLE 6 Corneal implants market, by end-use, 2014 - 2025 (USD Million)
TABLE 7 Corneal implants market, by region, 2014 - 2025 (USD Million)
TABLE 8 Industry impact forces
TABLE 9 Human donor market size, by region, 2014 - 2025 (USD Million)
TABLE 10 Artificial cornea market size, by region, 2014 - 2025 (USD Million)
TABLE 11 Anterior lamellar keratoplasty market size, by region, 2014 - 2025 (USD Million)
TABLE 12 Endothelial lamellar keratoplasty market size, by region, 2014 - 2025 (USD Million)
TABLE 13 Penetrating keratoplasty market size, by region, 2014 - 2025 (USD Million)
TABLE 14 Others market size, by region, 2014 - 2025 (USD Million)
TABLE 15 Fungal keratitis market size, by region, 2014 - 2025 (USD Million)
TABLE 16 Fuchs' dystrophy market size, by region, 2014 - 2025 (USD Million)
TABLE 17 Keratoconus market size, by region, 2014 - 2025 (USD Million)
TABLE 18 Others market size, by region, 2014 - 2025 (USD Million)
TABLE 19 Hospitals market size, by region, 2014 - 2025 (USD Million)
TABLE 20 Eye clinics market size, by region, 2014 - 2025 (USD Million)
TABLE 21 Ambulatory surgical centers market size, by region, 2014 - 2025 (USD Million)
TABLE 22 North America corneal implants size, by country, 2014 - 2025 (USD Million)
TABLE 23 North America corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 24 North America corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 25 North America corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 26 North America corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 27 U.S. corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 28 U.S. corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 29 U.S. corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 30 U.S. corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 31 Canada corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 32 Canada corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 33 Canada corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 34 Canada corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 35 Europe corneal implants size, by country, 2014 - 2025 (USD Million)
TABLE 36 Europe corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 37 Europe corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 38 Europe corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 39 Europe corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 40 Germany corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 41 Germany corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 42 Germany corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 43 Germany corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 44 UK corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 45 UK corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 46 UK corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 47 UK corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 48 France corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 49 France corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 50 France corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 51 France corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 52 Italy corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 53 Italy corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 54 Italy corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 55 Italy corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 56 Spain corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 57 Spain corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 58 Spain corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 59 Spain corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 60 Asia Pacific corneal implants size, by country, 2014 - 2025 (USD Million)
TABLE 61 Asia Pacific corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 62 Asia Pacific corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 63 Asia Pacific corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 64 Asia Pacific corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 65 China corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 66 China corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 67 China corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 68 China corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 69 India corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 70 India corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 71 India corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 72 India corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 73 Japan corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 74 Japan corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 75 Japan corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 76 Japan corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 77 Australia corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 78 Australia corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 79 Australia corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 80 Australia corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 81 South Korea corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 82 South Korea corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 83 South Korea corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 84 South Korea corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 85 Latin America corneal implants size, by country, 2014 - 2025 (USD Million)
TABLE 86 Latin America corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 87 Latin America corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 88 Latin America corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 89 Latin America corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 90 Brazil corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 91 Brazil corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 92 Brazil corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 93 Brazil corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 94 Mexico corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 95 Mexico corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 96 Mexico corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 97 Mexico corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 98 Argentina corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 99 Argentina corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 100 Argentina corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 101 Argentina corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 102 MEA corneal implants size, by country, 2014 - 2025 (USD Million)
TABLE 103 MEA corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 104 MEA corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 105 MEA corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 106 MEA corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 107 South Africa corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 108 South Africa corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 109 South Africa corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 110 South Africa corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 111 Saudi Arabia corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 112 Saudi Arabia corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 113 Saudi Arabia corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 114 Saudi Arabia corneal implants size, by end-use, 2014 - 2025 (USD Million)
TABLE 115 UAE corneal implants size, by tissue type, 2014 - 2025 (USD Million)
TABLE 116 UAE corneal implants size, by transplant type, 2014 - 2025 (USD Million)
TABLE 117 UAE corneal implants size, by condition, 2014 - 2025 (USD Million)
TABLE 118 UAE corneal implants size, by end-use, 2014 - 2025 (USD Million)
Charts & Figures
FIG. 1 Industry segmentation
FIG. 2 Global corneal implants market, 2014 - 2025 (USD Million)
FIG. 3 Growth potential analysis, by tissue type
FIG. 4 Growth potential analysis, by transplant type
FIG. 5 Growth potential analysis, by condition
FIG. 6 Growth potential analysis, by end-use
FIG. 7 Porter's analysis
FIG. 8 Company market share analysis, 2017
FIG. 9 Strategy dashboard
FIG. 10 PESTEL Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report